Active Ingredient History
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Automobiles (Early Phase 1)
Drugs, Investigational (Phase 1/Phase 2)
Hodgkin Disease (Phase 1)
Leukemia (Phase 1/Phase 2)
Leukemia, B-Cell (Phase 1/Phase 2)
Leukemia, Hairy Cell (Phase 1)
Leukemia, Lymphoid (Phase 1/Phase 2)
Lymphoma (Phase 1/Phase 2)
Lymphoma, B-Cell (Phase 1/Phase 2)
Lymphoma, B-Cell, Marginal Zone (Phase 1)
Lymphoma, Follicular (Phase 1)
Lymphoma, Large B-Cell, Diffuse (Phase 1)
Lymphoma, Large-Cell, Immunoblastic (Phase 1)
Lymphoma, Mantle-Cell (Phase 1)
Lymphoma, Non-Hodgkin (Phase 1)
Neoplasms (Phase 1/Phase 2)
Neoplasms, Plasma Cell (Phase 1)
Recurrence (Phase 1/Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
